Skip to content

Clinical Study of Methylcobalamin for Herpetic Neuralgia

Clinical Study of Methylcobalamin for Herpetic Neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034972
Enrollment
Unknown
Registered
2020-07-26
Start date
2020-08-15
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpetic Neuralgia

Interventions

Experimental group:Local Injection of Methylcobalamin
Control group:Local Injection of Lidocaine

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In patients with subacute herpetic neuralgia, the onset of herpes zoster is more than one month, but the pain time is not more than three months; 2. Patients aged 50 years =5.

Exclusion criteria

Exclusion criteria: 1. Patients with severe primary disease and unstable condition; 2. Patients with flaccid and non eruptive herpes zoster.

Design outcomes

Primary

MeasureTime frame
NRS scores;Pain area;Zoster Brief Pain Inventory;

Secondary

MeasureTime frame
GAP-43;PGP9.5;Sensory nerve conduction test;Sensory spectrum test;

Countries

China

Contacts

Public ContactXu Gang

Shanghai Tenth People's Hospital

shsykf@yeah.net+86 18917683646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026